Mike Stedman to Humans
This is a "connection" page, showing publications Mike Stedman has written about Humans.
Connection Strength
0.062
-
How fast should social restrictions be eased in England as COVID-19 vaccinations are rolled out? Int J Clin Pract. 2021 Jul; 75(7):e14191.
Score: 0.008
-
COVID-19: Generate and apply local modelled transmission and morbidity effects to provide an estimate of the variation in overall relative healthcare resource impact at general practice granularity. Int J Clin Pract. 2020 Sep; 74(9):e13533.
Score: 0.007
-
A phased approach to unlocking during the COVID-19 pandemic-Lessons from trend analysis. Int J Clin Pract. 2020 Aug; 74(8):e13528.
Score: 0.007
-
The costs of drug prescriptions for diabetes in the NHS. Lancet. 2019 01 19; 393(10168):226-227.
Score: 0.006
-
Real-world practice level data analysis confirms link between variability within Blood Glucose Monitoring Strip (BGMS) and glycosylated haemoglobin (HbA1c) in Type 1 Diabetes. Int J Clin Pract. 2018 Dec; 72(12):e13252.
Score: 0.006
-
Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England. Diabetes Obes Metab. 2018 07; 20(7):1659-1669.
Score: 0.006
-
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17. Int J Clin Pract. 2018 Apr; 72(4):e13080.
Score: 0.006
-
Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication. Int J Clin Pract. 2021 Dec; 75(12):e14714.
Score: 0.002
-
Age of people with type 2 diabetes and the risk of dying following SARS-CoV-2 infection. Int J Clin Pract. 2021 Aug; 75(8):e14053.
Score: 0.002
-
Analysis of Continuous Blood Glucose Data in People with Type 1 Diabetes (T1DM) After COVID-19 Vaccination Indicates a Possible Link Between the Immune and the Metabolic Response. J Diabetes Sci Technol. 2021 09; 15(5):1204-1205.
Score: 0.002
-
Modelling the impact of the mandatory use of face coverings on public transport and in retail outlets in the UK on COVID-19-related infections, hospital admissions and mortality. Int J Clin Pract. 2021 Mar; 75(3):e13768.
Score: 0.002
-
"Stay at Home, Protect the National Health Service, Save Lives": A cost benefit analysis of the lockdown in the United Kingdom. Int J Clin Pract. 2021 Mar; 75(3):e13674.
Score: 0.002
-
Personal protective equipment (PPE) and infection among healthcare workers - What is the evidence? Int J Clin Pract. 2020 Nov; 74(11):e13617.
Score: 0.002
-
Long-term conditions and the National Diabetes Audit. Br J Gen Pract. 2018 07; 68(672):320.
Score: 0.002
-
Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit. Diabet Med. 2018 01; 35(1):63-71.
Score: 0.001
-
Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit. Diabetes Obes Metab. 2018 01; 20(1):185-194.
Score: 0.001